Kenneth F. Baker

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Wearable- and Mobile App-Based Activity Pacing and Fatigue Management in Post-COVID-19 Condition: Exploratory Observational Study.

Wearable- and Mobile App-Based Activity Pacing and Fatigue Management in Post-COVID-19 Condition: Exploratory Observational Study.

Journal: JMIR formative research

Published: January 20, 2026

Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation.

Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation.

Journal: Annals of the rheumatic diseases

Published: November 11, 2025

Tapering towards drug-free remission in rheumatoid arthritis: assessment of clinical outcomes and drug savings.

Tapering towards drug-free remission in rheumatoid arthritis: assessment of clinical outcomes and drug savings.

Journal: Rheumatology advances in practice

Published: October 18, 2025

Feasibility of predicting next-day fatigue levels using heart rate variability and activity-sleep metrics in people with post-COVID fatigue.

Feasibility of predicting next-day fatigue levels using heart rate variability and activity-sleep metrics in people with post-COVID fatigue.

Journal: Frontiers in digital health

Published: August 21, 2025

Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study.

Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study.

Journal: BMJ open

Published: April 09, 2025

Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis.

Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis.

Journal: RMD open

Published: January 09, 2025

Systematic review: digital biomarkers of fatigue in chronic diseases.

Systematic review: digital biomarkers of fatigue in chronic diseases.

Journal: NPJ digital medicine

Published: November 18, 2024

Exploring the Effect of Sampling Frequency on Real-World Mobility, Sedentary Behaviour, Physical Activity and Sleep Outcomes Measured with Wearable Devices in Rheumatoid Arthritis: Feasibility, Usability and Practical Considerations.

Exploring the Effect of Sampling Frequency on Real-World Mobility, Sedentary Behaviour, Physical Activity and Sleep Outcomes Measured with Wearable Devices in Rheumatoid Arthritis: Feasibility, Usability and Practical Considerations.

Journal: Bioengineering (Basel, Switzerland)

Published: November 13, 2024

Cure as a treatment target in rheumatoid arthritis and systemic sclerosis-achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration.

Cure as a treatment target in rheumatoid arthritis and systemic sclerosis-achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration.

Journal: Annals of the rheumatic diseases

Published: September 13, 2024

Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study.

Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study.

Journal: Rheumatology international

Published: March 20, 2023

Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission.

Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission.

Journal: Nature communications

Published: January 22, 2023

COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes.

COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes.

Journal: Rheumatology (Oxford, England)

Published: December 13, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026